Confidential Enquiries · Institutional Counterparties Only
Insights 24 July 2026 ~6 minute read

Buy, Borrow, Die: Borrowing Against Stock Instead of Selling.

A phrase that travels well on the internet and badly in the details. What it actually describes is an old, unremarkable idea — borrow against an appreciated asset rather than sell it — and a middle step that is simply a securities-backed loan.

“Buy, borrow, die” is shorthand for holding appreciated assets, borrowing against them to fund spending rather than selling, and passing the assets on — deferring the disposal that a sale would crystallise. The middle step, “borrow,” is a securities-backed loan.

The phrase has become a piece of internet economics, invoked to explain how large holders of appreciated stock fund their lives without appearing to sell. Stripped of the mythology, it describes something specific and legitimate: rather than sell shares and trigger a taxable disposal, a holder pledges them and borrows cash, deferring the sale to a later date or a later generation. This note explains the mechanics of the “borrow” step, what makes it work, and — importantly — what the shorthand leaves out. It is general information, not tax, legal, or investment advice; the tax treatment in particular is jurisdiction-specific and a matter for the holder’s own advisers.

What the phrase actually means

The three words map to three steps. Buy: acquire and hold assets that appreciate — often a concentrated stake built by a founder or early investor. Borrow: instead of selling to raise cash, borrow against the position, so the asset keeps compounding and no disposal is triggered. Die: the estate-planning tail, in which the assets pass on and the accumulated liabilities are settled from the estate. The middle step is the only one this firm is concerned with, and it is nothing more exotic than a securities-backed loan — the instrument set out in What Is Securities-Backed Lending?

Why a holder borrows instead of sells

The appeal is not mysterious. Selling a large, appreciated position does three things a holder may not want: it ends the exposure to any further upside, it removes the shares from the holder’s control, and it can crystallise a capital-gains event. Borrowing against the position avoids all three. The holder keeps beneficial ownership, keeps the upside and the dividends, and defers — not avoids — the disposal. The general case for raising cash without a sale is set out in Can You Borrow Against Shares Without Selling?, and what holders do with the proceeds in What Founders Do With the Liquidity.

In a securities-backed loan the holder pledges the shares, receives cash against a fraction of their value — illustratively in the region of 20% to 65% depending on the name and structure — and recovers the full position on repayment. The tax treatment of borrowing rather than selling is genuinely different from a disposal, but it is specific to the holder’s jurisdiction and circumstances; the general terrain is mapped, without advice, in The Tax Treatment of Securities-Backed Loans.

What the shorthand leaves out

The internet version of “buy, borrow, die” tends to present it as free money. It is not. A securities-backed loan carries a cost — a reference rate plus a spread — and that cost compounds if the loan is rolled over years. If the borrowing rate exceeds the after-tax cost of simply selling, the arithmetic can turn against the strategy. And the collateral is live: a fall in the underlying can trigger a margin call, and an unmet call can force exactly the sale the holder was trying to avoid, at the worst possible moment. The mechanics of that risk are in Margin Call Mechanics.

The disciplined version of the strategy therefore looks nothing like the meme. It uses a conservative loan-to-value with a genuine buffer, sizes the borrowing to what the position can comfortably support through a drawdown, and treats the facility as deferral with a cost, not a free substitute for income. Structure, in other words, matters more than the slogan — the argument made in Why Structuring Beats Pricing.

Who actually uses it

In practice the holders for whom this makes sense are those with large, genuinely long-term positions they do not intend to sell in the near term: founders and controlling shareholders, early investors, and family offices holding a legacy stake. For them the “borrow” step is a deliberate, cost-aware decision to keep a position intact and raise liquidity against it — a securities-backed loan on conservative terms, arranged and documented properly, with the tax and estate dimensions handled by their own advisers. The strategy is real; the free-lunch version of it is not.

Written by

Etienne Marchand

Managing Principal

Etienne Marchand leads the firm’s structuring practice, with more than two decades arranging financing against concentrated listed-equity positions for founders, controlling shareholders, and family offices. He carries principal responsibility for transaction structuring across the firm’s global markets.

Securities-backed lending · Structured finance · Equity capital markets · Collateralised lending

FAQ
Common Questions

On this topic.

Q · 01 What does "buy, borrow, die" mean?
It is shorthand for a long-horizon approach to appreciated assets: buy and hold assets that grow in value, borrow against them to fund spending instead of selling, and pass them on, deferring the disposal a sale would trigger. The only step relevant to a financing arranger is the middle one — "borrow" — which in practice is a securities-backed loan: cash raised against pledged shares that remain owned.
Q · 02 Is borrowing against stock instead of selling legal?
Yes. Borrowing against a pledged position is an ordinary, legitimate financing transaction. The holder keeps beneficial ownership and receives a cash loan against the shares. What the holder must not do is treat it as tax advice or assume a particular tax outcome: whether and how borrowing differs from selling for tax purposes is specific to the holder’s jurisdiction and circumstances and is a matter for their own tax adviser.
Q · 03 Is it really free money?
No. A securities-backed loan has a cost — a reference rate plus a spread — which compounds if the loan runs for years, and if that cost exceeds the after-tax cost of selling, the strategy can lose its advantage. The collateral is also live: a fall in the underlying can trigger a margin call, and an unmet call can force the sale the holder was trying to avoid. The disciplined version uses a conservative loan-to-value and a real buffer.
Q · 04 How much can you borrow under this approach?
The same envelope as any securities-backed loan: illustratively in the region of 20% to 65% of the position’s value, driven by the name’s liquidity, volatility, free float, concentration, and the recourse profile. A prudent version of the strategy borrows well within that range so the position can absorb a drawdown without a margin call. The figure is a calculated output for the specific position, not a published rate.
Q · 05 Who is this actually suitable for?
Holders with large, genuinely long-term positions they do not plan to sell in the near term — founders, controlling shareholders, early investors, and family offices with a legacy stake. For them, borrowing against the position on conservative terms is a deliberate, cost-aware way to keep it intact while raising liquidity, with the tax and estate dimensions handled by their own advisers. It is not a substitute for income for a holder who cannot service or repay the loan.

A specific position to discuss?

Submit a confidential enquiry. A senior principal will respond within one business day.